Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials
M O Leach1, K M Brindle, J L Evelhoch
1Pharmacodynamic/Pharmacokinetic Technologies Advisory Committee (PTAC), Drug Development Office, Cancer Research UK, London, UK.
The British Journal of Radiology
|October 1, 2004
Abstract
No abstract available in PubMed .

